Heron Therapeutics Announces Appointment of Ira Duarte as Ch

SAN DIEGO, June 23, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet...

Related Keywords

David Szekeres , Chiesi Farmaceutici , Florida Atlantic University , Heron Therapeutics Inc , Financial Planning For Cornerstone Therapeutics Inc , Nasdaq , Ernst Young Global , Corporate Finance For Chiesi United States Inc , Exchange Commission , Cornerstone Therapeutics Inc , Terrascend Corporation , Biodelivery Sciences Inc , Veloxis Pharmaceuticals Inc , Heron Therapeutics , Ira Duarte , Chief Financial , Chief Financial Officer , Craig Collard , Chief Executive Officer , Veloxis Pharmaceuticals , Corporate Controller , Biodelivery Sciences , Senior Director , Corporate Finance , Chiesi United States , Financial Planning , Cornerstone Therapeutics , Senior Manager , Young Global , Certified Public Accountant , Florida Atlantic , Inducement Option , Nasdaq Capital Market , Nasdaq Listing Rule , Compensation Committee , Private Securities Litigation Reform Act , Media Contact , Vice President , Chief Operating , Markets ,